Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-13, with 33 holding rows worth $623,549,000.

Accession
0001567619-19-010466
Filed
2019-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 33 entries on the cover page, a total value of $623,549,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $623,549,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM1,358,470$64,813,000thousands by filing date
Abbott Laboratories002824100COM763,676$61,048,000thousands by filing date
Boston Scientific Corporation101137107COM1,115,174$42,800,000thousands by filing date
Gilead Sciences,Inc.375558103COM578,737$37,624,000thousands by filing date
BAXTER INTL INC071813109COM448,228$36,445,000thousands by filing date
BIOGEN INC COM09062X103Stock150,200$35,504,000thousands by filing date
REVVITY INC714046109COM343,081$33,059,000thousands by filing date
NUVASIVE INC670704105COM538,625$30,589,000thousands by filing date
BIO RAD LABS INC090572207CL A87,397$26,716,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock280,351$22,535,000thousands by filing date
INCYTE CORP COM45337C102Stock261,293$22,474,000thousands by filing date
MYLAN NVN59465109SHS EURO790,700$22,408,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock233,714$18,971,000thousands by filing date
QIAGEN NVN72482123SHS NEW396,990$16,150,000thousands by filing date
CVS Health Corporation126650100COM298,733$16,111,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock308,020$14,834,000thousands by filing date
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR647,451$13,189,000thousands by filing date
Elevance Health, Inc.036752103COM39,013$11,196,000thousands by filing date
Merck & Co.,Inc.58933Y105COM119,352$9,927,000thousands by filing date
PATTERSON COS INC703395103COM450,363$9,840,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM379,777$9,426,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock254,501$8,831,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock62,906$8,415,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM162,635$7,831,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM194,743$7,330,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock218,994$7,023,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock218,684$6,307,000thousands by filing date
MCKESSON CORP COM58155Q103Stock49,500$5,794,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM65,935$4,573,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM57,043$3,847,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR88,076$3,567,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM238,857$2,279,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK376,502$2,093,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-19-010466this filing2019-05-13acceptance time not in the bulk data set